News

Alliance Witan PLC Reports Latest Net Asset Values

Alliance Witan PLC Reports Latest Net Asset Values

Alliance Witan PLC's Recent Net Asset Value Update

ALLIANCE WITAN PLC

As the business world continues to evolve, understanding financial metrics such as Net Asset Value (NAV) is crucial. For Alliance Witan PLC, significant updates on NAV were reported recently, showcasing an ongoing commitment to transparency and investor relations.

Latest NAV Valuations

At the close of business on a specified recent Wednesday, the NAV per ordinary share for Alliance Witan was assessed on a bid price basis, taking into account various methods for valuing debt.

Here are the recorded values:

  • Excluding income: 1334.9p
  • Including income: 1330.4p

When considering debt at fair value, the figures differ slightly:

  • Excluding income: 1352.0p
  • Including income: 1347.5p

Understanding NAV Calculations

Calculating the NAV accurately is key to providing stakeholders with relevant information. This metric reflects the company's financial standing and is vital for investment decisions. Alliance Witan's NAV calculations follow established accounting policies and adhere to the guidelines set by the Association of Investment Companies (AIC).

Factors Influencing NAV

The determination of NAV incorporates various elements:

  • The fixed loan notes are evaluated based on their fair value, derived from a benchmark gilt.
  • Each dividend that is declared is factored into the ‘including income’ calculations.

Upcoming Dividend Information

In addition to the NAV figures, the company announced a dividend of 6.73p, planned for disbursement on a specified date in December. Notably, this dividend has already been deducted from each of the ‘including income’ amounts starting from a previous date, marking the shares as ex-dividend.

Contact Information for Further Inquiries

For those looking to delve deeper into the company’s financial particulars or seeking clarifications, they can reach out to Juniper Partners Limited, who assist with such inquiries:

Juniper Partners Limited
Tel: +44 (0)131 378 0500

Conclusion

As Alliance Witan PLC navigates through the financial timeline, its commitment to providing clarity and relevant data to its investors stands out. Keeping stakeholders informed about metrics such as NAV not only strengthens trust but also fosters an environment of informed decision-making. Investors are encouraged to stay updated on these financial insights and anticipate the impacts of declared dividends.

Frequently Asked Questions

What is the current NAV per share for Alliance Witan PLC?

The current NAV per ordinary share is 1334.9p excluding income and 1330.4p including income based on recent reports.

When is the upcoming dividend payment due?

The dividend of 6.73p is scheduled to be paid in December.

How is the NAV for Alliance Witan PLC calculated?

NAV is calculated according to accounting policies and AIC guidelines, reflecting the company's assets and liabilities.

Who should I contact for more information regarding Alliance Witan PLC?

For inquiries, you can contact Juniper Partners Limited at +44 (0)131 378 0500.

What benchmarks are used for evaluating fixed loan notes?

The fair value of fixed loan notes is assessed based on benchmark gilt performance, ensuring accurate valuations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 15

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

Pet Boarding Services Set for Major Market Expansion by 2032

Updated Category News Views 111

Overview of Pet Boarding Services Market Growth The pet boarding services market has been experiencing significant growth, projected to reach a substantial USD 29.5 billion by 2032. This increase is fueled by a strong trend in pet ownership and an overall rise in disposable incomes, allowing families to provide better care for their furry companions. It was valued at USD...

Continue Reading
Summit Therapeutics Q4 Earnings: A Closer Look at SMMT

Updated Category News Views 170

Summit Therapeutics: Lay of the Land After Q4 Earnings It's been a bumpy road for Summit Therapeutics, ya know? Just when you think they might pull through, they drop a bombshell. Released on February 23, 2026, their Q4 earnings report didn’t just miss the target—it got blasted off course. This wasn’t just a little hiccup; they missed estimated earnings by a...

Continue Reading
SAIC Board Approves Cash Dividend to Shareholders

Updated Category News Views 117

SAIC Board Approves Cash Dividend Science Applications International Corp. (NASDAQ: SAIC) has made an important announcement regarding its commitment to share ownership. Recently, the board of directors declared a cash dividend amounting to $0.37 per share, which signifies the company's dedication to returning value to its shareholders. This dividend is scheduled for...

Continue Reading
Innovative Steps to Enhance Affordable Housing in Canada

Updated Category News Views 271

Transforming Affordable Housing in Canada Far too many Canadians, especially younger individuals, are encountering difficulties in their quest for affordable housing options. In response, the government is unveiling an ambitious strategy paired with substantial investments aimed at enhancing the supply of accessible housing across the nation. Introducing Build Canada...

Continue Reading
Protecting Your Home: Smart Steps After Winter Storms

Updated Category News Views 117

Protecting Your Home: Smart Steps After Winter Storms Taking Action Now Can Minimize Future Damage With fluctuating temperatures following severe winter storms, homeowners and business owners must take proactive measures to prevent water damage and ensure a swift recovery. Mercury Insurance (NYSE: MCY) highlights the importance of acting strategically to protect...

Continue Reading